Roche Executive To Be Named Gilead Ceo

Gilead Sciences is planning to hire industry veteran Daniel O’Day to take the helm and help the drug company revive sales and recover from a disappointing deal.

Topics:  gilead sciences   daniel o day   
BING NEWS:
  • New CEO completes round trip through Roche back to Genentech
    Anderson, who had been in the CEO job since January 2017, was named last month as CEO of Roche Pharmaceuticals. That move came after Daniel O'Day, a former Genentech executive moved from Roche to ...
    01/25/2019 - 9:31 am | View Link
  • Roche dispatches strategy executive Alexander Hardy to take Genentech helm
    After Roche lost its top pharma executive Dan O’Day to Gilead Sciences, the cancer giant tapped Genentech head Bill Anderson for the post, leaving a gap at the top of its crucial unit. Now, Genentech ...
    01/24/2019 - 4:16 am | View Link
  • Roche's Genentech Names Alexander Hardy Chief Executive
    who was named chief executive of Gilead Sciences Inc. (GILD). Mr. Hardy first joined Genentech in 2005, where he held several senior management positions. In 2014, he became head of Asia Pacific for ...
    01/23/2019 - 10:10 pm | View Link
  • UPDATE 2-Gilead Sciences hires Roche executive Daniel O'Day as CEO
    Dec 10 (Reuters) - Drugmaker Gilead Sciences Inc named Roche Holding AG executive Daniel O'Day as its new chief executive officer, the companies said on Monday. Gilead said its board had appointed ...
    12/10/2018 - 2:38 pm | View Link
  • Gilead poaches Roche executive as new CEO
    Gilead Sciences has named Daniel O'Day — a longtime Roche Holdings executive — as its new CEO, according to The Wall Street Journal. Mr. O'Day will succeed John Milligan, who unexpectedly announced he ...
    12/10/2018 - 11:00 am | View Link
  • More
BING SEARCH:
  • Gilead Sciences Names Roche Executive as New Chairman and ...
    Gilead Sciences has appointed Daniel O’Day, currently Chief Executive Officer (CEO) of Roche Pharmaceuticals, as Chairman of the Board of Directors and CEO of Gilead, effective March 1, 2019. John C. Martin, current Chairman, Gilead Sciences’ Board of Directors, will step down from the company’s board, effective March 1, 2019.
    03/14/2019 - 8:28 pm | View Website
  • Roche Executive to Be Named Gilead CEO -- Update
    RHHBY Roche Holding (QX) Roche Executive to Be Named Gilead CEO -- Update By Jonathan D. Rockoff and Joseph Walker Gilead Sciences Inc. is planning to hire industry veteran Daniel O'Day to take the helm and help the drug company revive sales and recover from a d...
    03/14/2019 - 2:30 pm | View Website
  • Roche Executive Daniel O’Day Is Named Gilead CEO
    Gilead Sciences has hired industry veteran Daniel O’Day to take the helm and help the drug company revive sales and recover from a disappointing deal.
    03/13/2019 - 1:31 am | View Website
  • Roche executive Danial O'Day to be named Gilead CEO | Fox ...
    Roche executive Danial O'Day to be named Gilead CEO. Published December 10, 2018 Business Leaders The Wall Street Journal. ... Roche took the unusual step of pricing Ocrevus below many of its rivals.
    02/9/2019 - 5:22 pm | View Website
  • Gilead names Roche veteran O'Day as CEO | BioPharma Dive
    Gilead Sciences has named Daniel O'Day as its next chief executive, tapping the longtime Roche veteran to lead a push into new therapeutic markets like oncology and rejuvenate a business slowed by falling sales of its mainstay hepatitis C drugs.
    12/10/2018 - 12:15 pm | View Website
  • More
Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More News